Soros Fund Management’s Spyre Therapeutics SYRE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$2.02M Sell
2024
Q4
$5.82M Buy
2024
Q3
$4.26M Hold
2024
Q2
$3.41M Buy
2024
Q1
$1.14M Buy
2018
Q3
Sell
2018
Q2
$2.18M Buy